Project Grant K08AI181643
Award Date
8/7/24
Completion Date
7/31/28
Dollars Obligated
$196K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14642, USA
Similar Awards
This $315,000 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will be used by the Regents of the University of California at Riverside to conduct research on the interactions between the vaginal virome and bacterial vaginosis (BV), as well as the impact on HIV acquisition risk. The study aims to characterize the vaginal virome and its role in BV...
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $533,750.00 to the University of Florida to study the role of macrophages in the increased HIV risk associated with bacterial vaginosis (BV). The research aims to determine how a non-optimal vaginal microbiome affects the activation and "training" of macrophages towards an HIV-permissive phenotype. This will be...
This $173,030 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports the development of a novel assay for receptor-guided discovery of environmental bacteriophages (phages) using co-culture techniques. The project aims to create a generalized method to identify phages that require specific bacterial membrane proteins or structures for infection, which could aid...
This $700,350 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will fund a research project at Case Western Reserve University to define the neovaginal microbiome in transgender women who have undergone or will undergo gender-affirming vaginoplasty surgery. The study aims to investigate associations between the neovaginal microbiome, genital inflammation, and clinical outcomes such as gynecological...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,564,570 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa. The project will run from August 2024 through June 2029. The grant supports several key products and...
This $1,442,972 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a randomized controlled trial to investigate the impact of vaginal washing cessation on cervical inflammation and immune function among women at high risk for HIV acquisition in sub-Saharan Africa. The study aims to measure the effects of the intervention on cervicovaginal cytokine...
This $479,730 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research to elucidate the mechanisms by which prophages (viruses integrated into bacterial genomes) modulate the production of the antimicrobial compound reuterin in the probiotic gut bacterium Limosilactobacillus reuteri. The research aims to: 1) characterize the interplay between a prophage-derived protein...
This federal Project Grant award of $285,816 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to enhance the understanding of ADP-ribosylation (ADPR) in the biology of Human Immunodeficiency Virus 1 (HIV-1) through biochemical, proteomic, and cellular assays. The primary objectives are to: 1) Identify global proteomic changes to ADPR during HIV-1 latency and reactivation; 2) Investigate PARP-HIV-1...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $226,204 to the University of Maryland, Baltimore to investigate the vaginal microbiome and immune response factors that contribute to the spontaneous clearance of Chlamydia trachomatis (CT) infections in women. The key objectives are to: (1) evaluate species- and strain-specific vaginal bacterial growth rates, (2)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $483,000.00 to Case Western Reserve University to conduct research on defining the role of single-cell heterogeneity in bacterial vaginosis (BV). The overarching goal is to identify aspects of diversity that impact BV and provide insights into new strategies for prevention, treatment, and diagnosis. The...